GPHL attends the 1st China Innovation Conference and reaches agreement with We Doctor
2017-11-02 16:17:41 GPHL GPHL
The 2017 China Innovation Conference was held in Guangzhou on June 24. Li Chuyuan, chairman of GPHL was invited to this spectacular event and delivered a speech at the Conference.
On the same day, GPHL also reached an agreement on strategic cooperation with We Doctor—a digital hospital with an online diagnosis and treatment platform, facilitating profound integration of the Internet into the pharmaceutical industry. The two parties will reinforce the complementary advantages of medical partnerships, centralized purchase of medicine, drug and treatment stores and pharmaceutical logistics, together boosting the development of the Internet health and medicine industry in the Guangdong-Hong Kong-Macao Greater Bay Area.
Celebrities converge at the 2017 China Innovation Conference.
Li Chuyuan, chairman of GPHL delivered a themed speech.
The China Innovation Conference (CIC) is a world-class convention of international standard, approved by the Development Research Center of the State Council (DRC). The CIC aims to build up a platform for innovative communication, the Belt and Road Initiative, creative learning, resource integration and development of the innovation industry in light of the national high-end talent resource the DRC has and the comprehensive advantages of the Guangdong-Hong Kong-Macao Greater Bay Area, including the reform and opening up policy, innovative development and “first mover” privilege.
The biomedical industry is hailed as a growth industry, one of the key areas of the Fourth Industrial Revolution. At the 2017 China Innovation Conference with the theme of “From Passive Medical Care to Proactive Health care”, Li Chuyuan, chairman of GPHL was asked to give a speech based on the Fourth Industrial Revolution, analyzing the opportunity that implementation of the Information Technology/Information Communication Technology, Artificial Intelligence and Biopharmaceuticals (IAB) plan in Guangzhou brings to the biomedical and health industry. He further introduced the company’s advantages in industrial foundations, upper design, R&D, industry, Internet plus, culture and internationalization as well as its future planning. Li also claimed the company’s determination to pioneer the IAB plan.
As one of the largest pharmaceutical companies in China and the industry leader in Guangzhou, GPHL is as ever, committed to innovation. Currently, withNobel Prize laureates, 8 national R&D platforms and 13 innovative drugs in development, it is the pioneer in biotechnology within Guangzhou. In 2016 sales revenue surpassed RMB 87.8 billion and is expected to surpass RMB 100 billion this year.
GPHL reaches agreement on strategic cooperation with We Doctor.
Develop a diverse service featuring internet and medicine.
On the same day, GPHL signed a strategic cooperation agreement with We Doctor, marking the first collaboration between the first Internet medical partnership platform and a large pharmaceutical company after the State Council announced new policies on medical partnerships in April.
GPHL signs a cooperation agreement with We Doctor.
As the largest drug retailer in Guangzhou, GPHL has over 300 chain drugstores. Upon cooperation with Guangzhou digital hospital, its offline drugstores will join We Doctor and remote treatment systems, extending the business model from simple offline pharmaceutical sales to online treatment.
Regarding medical care, Guangzhou Baiyunshan Hospital under GPHL will become a member of We Doctor. As a supplier, GPHL will provide drugs, devices and materials for institutions within We Doctor.
At the signing ceremony, Li Chuyuan said that with the technology and resources of We Doctor, GPHL will have freer reign over its industrial edge and provide diversified and comprehensive medical and health services for users. He also stated that the cooperation set a good example for the integration of the IAB industry, unveiling a significant opportunity for both parties.
(Translator: Cheryl Ma; Editors: Simon Haywood, Olivia Yang, Monica Liu)